Administrative aspects
Financial information
The Agency’s total revenue in 2023 was EUR 461.54 million. In addition, the Agency operated with fund sources for assigned revenue, mainly CL for internal assigned revenue (rent and building charges received from the Agency’s subtenant in London) but also for R0 for external assigned revenue. In 2023, assigned revenue (funding sources R0 and CL) amounted to EUR 22.73 million.
Remuneration to national competent authorities
NCAs in the EU Member States receive a share of EMA’s revenue from fees for the assessments they carry out on behalf of the Agency. In 2023, EMA paid a total of EUR 153.97 million to the NCAs, compared to EUR 145.99 million in 2022. This figure includes payments for pharmacovigilance procedures, including the assessment of PSURs, PASS protocols and study results, and of pharmacovigilance-related referrals.
Agency staff
As of December 2023, the Agency had 982 staff members: 639 women and 343 men.
| Men | Women | Total | |
|---|---|---|---|
| Temporary agents | 253 | 411 | 664 |
| Contract agents | 52 | 164 | 216 |
| National experts | 23 | 25 | 48 |
| Trainees | 15 | 39 | 54 |
| Total | 343 | 639 | 982 |